Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randy Osborne

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Nature Biotechnology|April 9, 2008
Dynogen's SPACRandy Osborne
Nature Biotechnology|July 10, 2008
Commercial interest waxes for IGF-1 blockersRandy Osborne
Nature Biotechnology|August 9, 2008
FDA and surrogate endpoints in Alzheimer's diseaseRandy Osborne
Nature Biotechnology|October 15, 2010
Newsmaker: Constellation PharmaceuticalsRandy Osborne
Nature Biotechnology|February 9, 2013
First novel anti-tuberculosis drug in 40 yearsRandy Osborne
Nature Biotechnology|February 9, 2013
Fresh from the biotech pipeline--2012Randy Osborne
Nature Biotechnology|June 11, 2009
Masters of their universeRandy Osborne, Laura DeFrancesco
Nature Biotechnology|November 11, 2008
FDA cracks down on labeling, initiates trial result reportingRandy Osborne, Emily Waltz
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Nature Biotechnology|April 9, 2008
Dynogen's SPACRandy Osborne
Nature Biotechnology|July 10, 2008
Commercial interest waxes for IGF-1 blockersRandy Osborne
Nature Biotechnology|August 9, 2008
FDA and surrogate endpoints in Alzheimer's diseaseRandy Osborne
Nature Biotechnology|October 15, 2010
Newsmaker: Constellation PharmaceuticalsRandy Osborne
Nature Biotechnology|February 9, 2013
First novel anti-tuberculosis drug in 40 yearsRandy Osborne
Nature Biotechnology|February 9, 2013
Fresh from the biotech pipeline--2012Randy Osborne
Nature Biotechnology|June 11, 2009
Masters of their universeRandy Osborne, Laura DeFrancesco
Nature Biotechnology|November 11, 2008
FDA cracks down on labeling, initiates trial result reportingRandy Osborne, Emily Waltz
Pageof 2